BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31876426)

  • 1. Ultrasound-Assisted miR-122-Loaded Polymeric Nanodroplets for Hepatocellular Carcinoma Gene Therapy.
    Guo H; Xu M; Cao Z; Li W; Chen L; Xie X; Wang W; Liu J
    Mol Pharm; 2020 Feb; 17(2):541-553. PubMed ID: 31876426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-Triggered Phase-Transition Cationic Nanodroplets for Enhanced Gene Delivery.
    Gao D; Xu M; Cao Z; Gao J; Chen Y; Li Y; Yang Z; Xie X; Jiang Q; Wang W; Liu J
    ACS Appl Mater Interfaces; 2015 Jun; 7(24):13524-37. PubMed ID: 26016606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Ultrasound-Triggered Phase Transition Nanodroplets for Her2-Overexpressing Breast Cancer Diagnosis and Gene Transfection.
    Gao D; Gao J; Xu M; Cao Z; Zhou L; Li Y; Xie X; Jiang Q; Wang W; Liu J
    Mol Pharm; 2017 Apr; 14(4):984-998. PubMed ID: 28282145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-Mediated Gene Therapy of Hepatocellular Carcinoma Using Pre-microRNA Plasmid-Loaded Nanodroplets.
    Dong W; Wu P; Zhou D; Huang J; Qin M; Yang X; Wan M; Zong Y
    Ultrasound Med Biol; 2020 Jan; 46(1):90-107. PubMed ID: 31668943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multipotent miRNA Sponge-Loaded Magnetic Nanodroplets with Ultrasound/Magnet-Assisted Delivery for Hepatocellular Carcinoma Therapy.
    Dong W; Wu P; Qin M; Guo S; Liu H; Yang X; He W; Bouakaz A; Wan M; Zong Y
    Mol Pharm; 2020 Aug; 17(8):2891-2910. PubMed ID: 32678617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound triggered phase-change nanodroplets for doxorubicin prodrug delivery and ultrasound diagnosis: An in vitro study.
    Gao J; Yu B; Li C; Xu M; Cao Z; Xie X; Wang W; Liu J
    Colloids Surf B Biointerfaces; 2019 Feb; 174():416-425. PubMed ID: 30481702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal assessment of ultrasound-guided complementary microRNA therapy of hepatocellular carcinoma.
    Chowdhury SM; Lee T; Bachawal SV; Devulapally R; Abou-Elkacem L; Yeung TA; Wischhusen J; Tian L; Dahl J; Paulmurugan R; Willmann JK
    J Control Release; 2018 Jul; 281():19-28. PubMed ID: 29758233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photothermal-Enhanced Phase-Transition Nanodroplets for Ultrasound-Mediated Diagnosis and Gene Transfection.
    Gao J; Yu B; Li C; Wang W; Xu M; Cao Z; Xie X; Liu J
    ACS Biomater Sci Eng; 2019 Mar; 5(3):1366-1377. PubMed ID: 33405612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker.
    Li F; Wang F; Zhu C; Wei Q; Zhang T; Zhou YL
    Int J Nanomedicine; 2018; 13():2295-2307. PubMed ID: 29713162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
    Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
    J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound-triggered release of miR-199a-3p from liposome nanobubbles for enhanced hepatocellular carcinoma treatment.
    Guo X; Lin J; Pan L; He K; Huang Z; Chen J; Lin C; Zeng B; Luo S; Wang M
    Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):560-571. PubMed ID: 37850395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
    Rapoport N; Gao Z; Kennedy A
    J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Highly Efficient One-for-All Nanodroplet for Ultrasound Imaging-Guided and Cavitation-Enhanced Photothermal Therapy.
    Qin D; Zhang L; Zhu H; Chen J; Wu D; Bouakaz A; Wan M; Feng Y
    Int J Nanomedicine; 2021; 16():3105-3119. PubMed ID: 33967577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinicopathological significance of miR-149 and PARP-2 in hepatocellular carcinoma and their roles in chemo/radiotherapy.
    Lin L; Zhang YD; Chen ZY; Chen Y; Ren CP
    Tumour Biol; 2016 Sep; 37(9):12339-12346. PubMed ID: 27300349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma.
    Cai C; Xie Y; Wu L; Chen X; Liu H; Zhou Y; Zou H; Liu D; Zhao Y; Kong X; Liu P
    Sci Rep; 2017 Apr; 7():46250. PubMed ID: 28387375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor.
    Hsu SH; Yu B; Wang X; Lu Y; Schmidt CR; Lee RJ; Lee LJ; Jacob ST; Ghoshal K
    Nanomedicine; 2013 Nov; 9(8):1169-80. PubMed ID: 23727126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
    Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
    J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles.
    Zhao P; Li M; Wang Y; Chen Y; He C; Zhang X; Yang T; Lu Y; You J; Lee RJ; Xiang G
    Acta Biomater; 2018 May; 72():248-255. PubMed ID: 29555460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes.
    Zhang W; Peng F; Zhou T; Huang Y; Zhang L; Ye P; Lu M; Yang G; Gai Y; Yang T; Ma X; Xiang G
    Int J Nanomedicine; 2015; 10():4825-36. PubMed ID: 26251599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells.
    Mao C; Liu H; Chen P; Ye J; Teng L; Jia Z; Cao J
    Oncotarget; 2015 Mar; 6(8):5707-19. PubMed ID: 25691059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.